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Lipid A induction of cytotoxic antibody to cultured syngeneic rat
kidney tubular cells. Syngeneic Fischer rat kidneys repeatedly
injected with lipid A induced a cytotoxic antibody to cultured
syngeneic rat kidney tubular cells. To test for antibodies in the
serum of immunized animals, we disaggregated syngeneic rat
kidney tubular cells with collagenase and trypsin and established
them in short-term culture. Cultured kidney tubule cells were
then radiolabeled 24 hours later with chromium 51 and cultured
for an additional 24 hours. Rabbit antirat kidney tubule cell anti-
body served as the positive control antisera in a complement-
dependent antibody cytotoxicity assay. Serum samples from ani-
mals whose kidneys were innoculated with Re glycolipid were
then tested for antibody cytotoxicity. Autoantibody to syngeneic
cWtured kidney tubule cells was present in the serum from these
animals (P <0.01) as well as in the serum of animals injected i.p.
with Re glycolipid when compared with saline controls. The
cytotoxic antibody could be removed by absorbing with synge-
neic cultured kidney tubule cell membranes. These results sug-
gest that the glycolipid from the mutant strain Re 595 of Salmo-
nella minnesota stimulates a crossreactive antibody to cultured
rat kidney tubular cells. The methodology used in these experi-
ments provides an in vitro model for investigating the importance
of the immune system in the pathogenesis of pyelonephritis.
Induction par le lipide A d'un anticorps cytotoxique contre les
cellules tubulaires rénales en culture. Les reins de rats syngé-
niques Fischer injectés avec du lipide A induisent un anticorps
cytotoxique contre les cellules tubulaires cultivées de rats syngé-
niques. Pour évaluer les anticorps dans le serum des animaux
immunisés, des cellules tubulaires rénales de rats syngéniques
ont Cté désagrégées par la collagénase et Ia trypsine et placées
en culture a court terme. Les cellules cultivées ont été marquees
24 heures après par chromium 51 et cultivées pendant encore 24
heures. De l'anticorps de lapin anticellules tubulaires rénales de
rat a servi d'antisérum de contrôle positif dans un test
d'anticorps cytotoxique dépendant du complement. Les serums
des animaux dont les reins avaient été inoculés avec du glycoli-
pide Re ont alors été testes pour la cytotoxicité par anticorps.
Des auto-anticorps dirigés contre les cellules tubulaires rénales
syngéniques en culture existaient dans le serum de ces animaux
(P < 0,01) de méme que dans le serum d'animaux injectés par
voie intra-péritonéale avec le glycolipide Re, cela par corn-
paraison avec des contrôles qui avaient recu un solute sale. Les
anticorps cytotoxiques ont pu être prélevés par absorption au
moyen de membranes de cellules tubulaires rénales syngéniques
en culture. Ces résultats suggèrent que le glycolipide Re de Sal-
monella minnesota Re 595 stimule un anticorps croisé contre les
cellules tubulaires de rat en culture. La méthodologie employee
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dans ces experiences fournit un modèle in vitro qui permet
l'étude de l'importance du système immun dans Ia pathogénie de
Ia pyélonéphrite.
The mechanism of kidney tubular cell death in
acute and chronic pyelonephritis is not completely
understood, yet there is presently increasing evi-
dence to implicate the importance of the immune
system in the pathogenesis of this disease. Injection
of heat-killed Escherichia coli into the kidney pa-
renchyma results in pathologic lesions simulating
pyelonephritis, whereas less severe lesions are seen
in immunosuppressed animals [1]. Some investiga-
tors indicate that bacterial antigens may persist in
the kidneys for prolonged periods following active
infection [2—4]. Other studies are, however, at vari-
ance with these findings [5]. In addition to these re-
ports, Hemstreet has observed that plasma mem-
branes from pyelonephritic kidneys stimulated blast
transformation of autologous blood lymphocytes
[6]. In contrast, plasma membranes from normal
kidneys failed to stimulate the blast transformation.
These observations support the possibility that
tubular cell membranes may contain bacterial anti-
gens capable of eliciting either a cellular or a humor-
al autoimmune response. The ability of the endo-
toxic glycolipid from the mutant strain Re 595 of
Salmonella minnesota (Re glycolipid) to bind to
plasma membranes suggests that the Re glycolipid
may function as an immunologic adjuvant, stimu-
late crossreactive antibodies, or produce an autoim-
mune response by acting as a neoantigen [7—10].
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Herein, we report the ability of endotoxic lipo-
polysaccharide from Salmonella minnesota Re 595
to stimulate an autoantibody to kidney tubular cells.
Salmonella minnesota Re 595, often referred to as a
KDO-lipid A derivative [9, 11], was chosen because
the lipid A lacks 0 and K antigen specificity [9]. In
these experiments, rat kidneys were repeatedly in-
jected with the Re glycolipid. Repeated injection of
the Re glycolipid into the kidney stimulated a cyto-
toxic antibody to radioisotope-labeled cultured
syngeneic tubular cells. The potential importance of
these antibodies in the pathogeneis of pyelonephri-
tis is discussed.
Methods
Male and female rats (Fischer, Charles River
Breeding, North Wilmington, Maryland), each
weighing between 220 and 335 g, were used in these
experiments. Throughout the experiments, the rats
had continuous access to Purina rat pellets and
drinking water.
Endotoxin. A lipopolysaccharide (LPS) known as
Re glycolipid was extracted from a mutant strain
(Re 595) of Salmonella minnesota with chloroform
and methanol (4:1) and partially purified by meth-
anol precipitation according to the procedure of
Chen et al [11].
Immunization technique. To obtain a positive-
control antibody, three normal rabbits were inject-
ed with rat kidney tubular cells according to the
procedure of Linder [12]. The rabbit antirat kidney
antibody titer was evaluated by Trypan blue dye ex-
clusion and by chromium 51 isotope techniques [13,
14].
Rats were then immunized with Re glycolipid
(LPS). Under barbital anesthesia, a midline abdom-
inal incision was made and the right kidney ex-
posed. With a 27-gauge one-half-inch needle and a
1-cc tuberculin syringe, 0.05 ml of 100 g/ml con-
centration of Re glycolipid in normal saline was in-
jected into the lower pole of the right kidney. The
contralateral kidney was similarly injected with 0.05
ml of normal saline, and the midline incision was
closed with cuticular sutures. The procedure was
repeated once weekly up to 7 weeks. One week fol-
lowing the final injection, serum was collected from
blood samples obtained via cardiac puncture, and
the kidneys were removed for histologic studies
[15]. A second group of six rats received intrarenal
injections of saline only, and serum samples were
collected from them and tested.
A third group of six rats were injected i.p. once
weekly for 6 weeks with 1 ml of the Re glycolipid
(LPS) at a concentration of 1 mg/ml. A fourth group
of six rats were sham injected i.p. with an equal vol-
ume of saline. Serum samples were collected from
these two groups in the usual manner and tested for
cytotoxicity.
Chromium 51 labeling of cultured rat kidney
tubular cells. Prior to chromium 51 labeling, the rat
kidney tubular cells were disassociated for culture
according to the technique described by Kreisberg,
Pitts, and Pretlow [16]. Disaggregated cells (10 X
106) in tissue culture flasks were washed with phos-
phate buffered saline (PBS) (Gibco). RPMI-1640
medium (3 ml) containing 100 Ci of chromium 51
was then added to each flask. These flasks were
then incubated at 370 C for 1 hour. After incubation,
the kidney tubular cells were washed with PBS and
removed from the flasks by using 0.25% trypsin.
Approximately 3 X 10 cells in 0.2 ml of RPMI-1640
medium with 10% fetal bovine serum (FBS) were
placed into each well of a multiwell culture plate
(Linbro Scientific, Inc., Camden, Connecticut).
The plates were placed in a 37° C carbon dioxide
incubator.
Antibody-mediated cytotoxicity test. Twenty to
twenty-four hours following chromium 51 labeling,
the cytotoxicity test was initiated. After the cul-
tured kidney cells were washed with PBS, 50 l of
either antibody or FBS was added to the appropri-
ate wells and allowed to incubate at room temper-
ature for 20 mm. Following the incubation, 200 l of
barbital buffer solution was added to each well and
incubated for 10 mm. The supernatants were aspi-
rated, and either 50 l of guinea pig complement
diluted 1:2 or 50 .il of FBS was added to appropriate
wells and incubated for 45 mm at 37° C. After in-
cubation, 150 jsl of PBS was added to each well.
From each well, 100 p1 of supernatant was re-
moved, placed in appropriate tubes, and counted in
a gamma counter (Beckman Gamma 8000). The re-
maining supernatant and cells were frozen and
thawed three times before being placed in the ap-
propriate tubes and counted.
Statistical analysis. Statistical analysis of the
data was done by the method of multiple linear re-
gression applied to analysis of variance [17].
Results
Standardized rabbit antirat chromium 51 assay.
A positive complement-dependent antibody cyto-
toxicity assay was developed. Rabbits were hyper-
immunized with rat kidney tubular antigen, and an
effective guinea pig complement titer was estab-
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lished. Figure 1 demonstrates the cytotoxicity
curve of positive-control antisera. Incubation of the
kidney tubular cells for 24 hours after chromium 51
labeling reduced the background release to 15 to
20%, as demonstrated at the dilution of 1:1024.
There was a slight prozone effect at the higher anti-
body concentration. In subsequent experiments,
the positive-control antisera was used at a dilution
of 1:16.
Cytotoxic antibody to cultured syngeneic kidney
tubular cells by intraparenchymal injection of Re
glycolipid. Six animals were injected intrarenally
for 6 weeks and the sera tested for cytotoxic anti-
body to chromium-5 1-labeled cultured kidney tubu-
lar cells. Figure 2 depicts the cytotoxicity titer
of six different rat sera after six injections with
endotoxic glycolipid from Salmonella minnesota
Re 595. These were compared with the serum sam-
ples from six intrarenally saline-injected rats and
6 uninjected rats. Maximal killing was observed
by using full strength antisera with a 1:2 dilution
of guinea pig complement. Cytotoxicity in the
endotoxin-injected animals was 10 to 13% higher
than that in the saline-injected animals. These dif-
ferences were statistically significant (P < 0.01).
Differences in cytotoxicity between the saline-in-
jected and the sham-injected animals were not sta-
tistically significant (P > 0.05).
Absorption of cytotoxic antibody with kidney
tubular plasma membranes. Immune sera were ab-
sorbed to plasma membranes prepared from kidney
tubular cells by sucrose gradient ultracentrifugation
[18]. By an analysis of variance (P <0.05) in three
different experiments with antisera obtained from
• Normal rats.
0 Saline-injected rats
LPS-injected rats
four different animals, a significant decrease in the
cytotoxic antibody titer in the absorbed antisera
was seen when compared with the unabsorbed anti-
sera (Fig. 3).
Intraperitoneal injection of endotoxin from Sal-
monella minnesota Re 595 to stimulate cytotoxic
antibody. The serum samples from the six animals
that were injected i.p. with Re glycolipid were com-
pared with the serum from the positive-control im-
mune rabbits and the six control saline-injected
rats. All three groups were significantly different
from each other (P <0.01), as shown in Fig. 4.
Discussion
A variety of animal models have been established
for investigating the interaction of the host's im-
mune system with an infecting bacterial agent.
These models include antegrade and retrograde in-
fection with viable organisms [4, 19], as well as the
direct injection of living or dead organisms into the
kidney parenchyma [1, 20]. In our studies, we di-
rectly injected a defined Re glycolipid from Salmo-
nella minnesota mutant strain Re 595 into the kid-
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Fig. 1. Plot of the rabbit positive-control serum. The rabbit was
immunized four times to stimulate antibody production, and its
serum was absorbed with rat liver membranes and rat red blood
cells. The complement used in this experiment was at a 1:2 dilu-
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Fig. 2.Serum samples from normal and saline-injected rats com-
pared with serum samples from rats injected with Re glycolipid
(LPS). Solid triangles (A-A) denote mean data from six rats in-
jected six times with LPS into the right kidney. Open circles
(0-0) denote mean data from six rats injected six times with
saline into the right kidney. Closed circles (•-S) denote mean
data from six normal noninjected animals. At a dilution of 1:1
and 1:2, the serum from the control group and the serum from
saline-injected group are not different from each other (P> 0.05)
but are significantly different from LPS-injected animals
(P < 0.01). At the 1:4 and 1:8 dilutions, there are no significant
differences among any of the groups (P> 0.05).
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Fig. 3. Results of three separate experiments where serum was
taken from animals injected intrarenally with LPS, was absorbed
to rat kidney membranes, and then was tested for cytotoxicity
against radiolabeled cultured rat kidney tubule cells. A and B
Data of one rat serum. A significant difference between the
unabsorbed and the absorbed serum exists only at a 1:1 dilution
(P < 0.01). C Pooled serum from two different animals. Again
only at the 1:1 dilution of the sera was a significant difference
found (P < 0.01).
ney parenchyma. Repeated injection of Re glyco-
lipid into the kidney parenchyma caused a pathologic
lesion similar to that found in pyelonephritis [21,
22]. The value of the experimental design in this
study is that (1) it provides a model for studying im-
munologic mechanisms involved in the pathogene-
sis of kidney tubular cell death and (2) it provides an
opportunity to investigate the importance of bio-
chemically defined bacterial antigenic components.
A number of immunologic mechanisms may be
postulated to explain the development of cytotoxic
antibody in this study and the importance of this
development in the pathogenesis of kidney tubular
cell death. Re glycolipid (endotoxin) could (1) func-
tion as an immunologic adjuvant in breaking self tol-
erance, (2) stimulate antibodies crossreactive with
kidney tubular cells, or (3) bind to cultured kidney
tubular cells and act as a neoantigen. It is also pos-
sible that the mechanisms of kidney tubular cell
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Fig. 4. Plot of percent cytotoxicity vs serum dilution of normal
rat serum as compared with rabbit antirat serum and with serum
from rats injected six times i.p. with a 1-mg/mi solution of LPS.
Data points are plotted with the standard error of the mean. The
data from serum samples were significantly different from each
other at all titers (P < 0.01).
death in vivo may vary depending on the bacterial
antigens and may involve none, any one, or a com-
bination of the above.
Initially, it was suspected that the endotoxic gly-
colipid preparation was acting as an immunologic
adjuvant stimulating an antibody to kidney tubular
cells. This mechanism would be analogous to the
antibodies observed in the Heymann nephritis mod-
el [23]. In the experiments of Heymann et al, rats
produced autoantibodies to several renal tubular
antigens when hyperimmunized with kidney cortex
and complete Freund's adjuvant. In these studies,
the primary antigen was located on the brush border
of the proximal kidney tubular cell, and fluorescent
antibodies were crossreactive with proximal kidney
tubular antigens in other species [24].
In contrast, in our studies, cytotoxic antibodies
developed in animals injected i.p., supporting the
hypothesis that there are antigenic determinants on
the Re glycolipid that stimulate antibodies crossre-
active with cultured rat kidney tubular cells rather
than the supposition that the endotoxic glycolipid is
acting as an adjuvant. Crossreactive antibodies
have been identified in a number of different sys-
tems. Antibodies to Tamm-Horsfall protein have
been identified by Hanson, Fasth, and Jodal [25]. In
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addition, strains of E. coli with specific 0-somatic
antigens stimulate antibodies that are crossreactive
with kidney tubular cells [26]. To our knowledge
this is the first time a lipid A component has been
shown to stimulate a cytotoxic antibody that is
crossreactive with kidney tubular cells. The low
antibody titers in our experimental system (even af-
ter hyperimmunization) may be because the anti-
bodies are only cytotoxic to a subpopulation of kid-
ney tubular cells. Fluorescent antibody studies are
currently in progress to test this possibility, as well
as to determine if these animals develop immune
complex disease after intrarenal or i. p. injection
[27].
The antibody to Re glycolipid detected in vitro
may also function in vivo by lysing Re-glycolipid-
sensitized targets, that is, the neoantigen mecha-
nism. In support of this hypothesis, Shands dem-
onstrated the binding of LPS to red blood cell
stroma [10], and Springer et al subsequently puri-
fied lipid A specific receptors on leukocytes, plate-
lets, and red blood cells [8, 28]. Recent experiments
demonstrate that responder C3H/HeN mice kidney
tubular cell plasma membranes bind more Re gly-
colipid than do nonresponder (C3H/HeJ) kidneys.
Animal kidney tubular responder cells incubated in
vitro with Re glycolipid and anti-Re-glycolipid anti-
body are also lysed in the presence of complement
(Hemstreet et al, submitted for publication). In
vivo, the renal lesion is significantly less severe in
the nonresponder when compared with the re-
sponder strain [21]. One explanation for the lack of
killing in nonresponder animals may be that the
density of the LPS receptors is too low to effect
antibody-complement cell lysis.
The addition of 0 antigens to the lipid A back-
bone may be another important parameter influenc-
ing the pathogenesis of kidney tubular cell death be-
cause receptors for E. coli 0 and K antigens have
also been demonstrated on human kidney brush
borders [7]. These sites may not only be important
for bacterial attachment and penetration but may fa-
cilitate immunologic destruction of the kidney tubu-
lar cells. Thus, the virulence factor associated with
O and K antigen could also be mediated through the
immunologic mechanisms described above.
Summary. An in vitro model system has been de-
veloped to study the immunologic mechanisms that
may be involved in pyelonephritis. In this study, an-
imals injected intrarenally with endotoxic Re gly-
colipid from Salmonella minnesota Re 595 devel-
oped a cytotoxic antibody to syngeneic cultured
kidney tubular cells. Animals injected i.p. also de-
veloped cytotoxic antibody, indicating that the Re
glycolipid has an antigenic determinant cross-
reactive with cultured rat kidney tubular cells. The
importance of these antibodies in the pathogenesis
of pyelonephritis in vivo remains to be defined.
Based on observations in other studies, we have
proposed a requirement for a three-component sys-
tem involving the binding of Re glycolipid to the
kidney tubular cell, antibody, and/or cellular im-
mune mechanisms.
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